Rho site logo

Clinical Endpoints: What do payers and regulators want?

clinical endpoint selectionFailure to select the right clinical endpoint(s) can spell disaster for your product. In this article, Dr. Jack Modell, Senior Medical Officer, and Dr. David Shoemaker discuss how to select clinical endpoints that support both marketing approval by regulatory agencies such as FDA and reimbursement by payers. 

Discussion topics include:

        • Direct and surrogate endpoints
        • The importance of identifying a clinically significant unmet need
        • Advantages of using established, validated endpoints

Download this article now to learn more about selecting clinical endpoints that can lead your product to success.